120 related articles for article (PubMed ID: 1312194)
21. The mechanisms and significance of the coupled release of endothelium-derived relaxing factor (EDRF) and prostacyclin (PGI2) from endothelial cells.
Hyslop S; de Nucci G
Wien Klin Wochenschr; 1991; 103(14):422-34. PubMed ID: 1926869
[TBL] [Abstract][Full Text] [Related]
22. Angiotensin II-induced constrictions are masked by bovine retinal vessels.
Kulkarni PS; Hamid H; Barati M; Butulija D
Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):721-8. PubMed ID: 10067976
[TBL] [Abstract][Full Text] [Related]
23. Interactions between nitric oxide and prostacyclin in myocardial ischemia and endothelial cell cultures.
Schrör K; Woditsch I; Strobach H; Schröder H
Basic Res Cardiol; 1991; 86 Suppl 2():117-25. PubMed ID: 1659372
[TBL] [Abstract][Full Text] [Related]
24. Release of endothelium-derived relaxing factor from pig cultured aortic endothelial cells, as assessed by changes in endothelial cell cyclic GMP content, is inhibited by a phorbol ester.
Smith JA; Lang D
Br J Pharmacol; 1990 Mar; 99(3):565-71. PubMed ID: 1691949
[TBL] [Abstract][Full Text] [Related]
25. EDRF and nitric oxide production in cultured endothelial cells: direct inhibition by E. coli endotoxin.
Myers PR; Wright TF; Tanner MA; Adams HR
Am J Physiol; 1992 Mar; 262(3 Pt 2):H710-8. PubMed ID: 1558180
[TBL] [Abstract][Full Text] [Related]
26. Endothelium-derived relaxing factor (EDRF) from cultured and fresh endothelial cells.
Gryglewski RJ; Trybulec M; Radziszewski W; Swierkosz T; Dudek R; Zembowicz A
Biomed Biochim Acta; 1988; 47(10-11):S61-6. PubMed ID: 2470361
[TBL] [Abstract][Full Text] [Related]
27. Bioassay of prostacyclin and endothelium-derived relaxing factor (EDRF) from porcine aortic endothelial cells.
Gryglewski RJ; Moncada S; Palmer RM
Br J Pharmacol; 1986 Apr; 87(4):685-94. PubMed ID: 3085757
[TBL] [Abstract][Full Text] [Related]
28. Alkaline buffers release EDRF from bovine cultured aortic endothelial cells.
Mitchell JA; de Nucci G; Warner TD; Vane JR
Br J Pharmacol; 1991 Jun; 103(2):1295-302. PubMed ID: 1884092
[TBL] [Abstract][Full Text] [Related]
29. Nitric oxide but not prostacyclin is an autocrine endothelial mediator.
Schröder H; Strobach H; Schrör K
Biochem Pharmacol; 1992 Feb; 43(3):533-7. PubMed ID: 1371684
[TBL] [Abstract][Full Text] [Related]
30. Endothelium-derived bradykinin: implications for angiotensin-converting enzyme-inhibitor therapy.
Busse R; Fleming I; Hecker M
J Cardiovasc Pharmacol; 1993; 22 Suppl 5():S31-6. PubMed ID: 7508049
[TBL] [Abstract][Full Text] [Related]
31. Chronic exposure of cultured endothelial cells to eicosapentaenoic acid potentiates the release of endothelium-derived relaxing factor(s).
Boulanger C; Schini VB; Hendrickson H; Vanhoutte PM
Br J Pharmacol; 1990 Jan; 99(1):176-80. PubMed ID: 2158833
[TBL] [Abstract][Full Text] [Related]
32. Different patterns of release of endothelium-derived relaxing factor and prostacyclin.
Mitchell JA; de Nucci G; Warner TD; Vane JR
Br J Pharmacol; 1992 Feb; 105(2):485-9. PubMed ID: 1373103
[TBL] [Abstract][Full Text] [Related]
33. Methylene blue but not changes in cyclic GMP inhibits resting and bradykinin-stimulated production of prostacyclin by pig aortic endothelial cells.
Martin W; Drazan KM; Newby AC
Br J Pharmacol; 1989 May; 97(1):51-6. PubMed ID: 2541859
[TBL] [Abstract][Full Text] [Related]
34. Nitric oxide but not prostacyclin has an autocrine function in porcine aortic endothelial cells.
Schröder H; Machunsky C; Strobach H; Schrör K
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():671-4. PubMed ID: 1825396
[No Abstract] [Full Text] [Related]
35. Probing of the canine mammary artery damages endothelium and impairs vasodilation resulting from prostacyclin and endothelium-derived relaxing factor.
Johns RA; Peach MJ; Flanagan T; Kron IL
J Thorac Cardiovasc Surg; 1989 Feb; 97(2):252-8. PubMed ID: 2492624
[TBL] [Abstract][Full Text] [Related]
36. The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide.
Radomski MW; Palmer RM; Moncada S
Br J Pharmacol; 1987 Nov; 92(3):639-46. PubMed ID: 3322462
[TBL] [Abstract][Full Text] [Related]
37. Endothelium-derived relaxing factor and atriopeptin II elevate cyclic GMP levels in pig aortic endothelial cells.
Martin W; White DG; Henderson AH
Br J Pharmacol; 1988 Jan; 93(1):229-39. PubMed ID: 2894877
[TBL] [Abstract][Full Text] [Related]
38. Cytokine-mediated induction of cyclo-oxygenase-2 by activation of tyrosine kinase in bovine endothelial cells stimulated by bacterial lipopolysaccharide.
Akarasereenont P; Bakhle YS; Thiemermann C; Vane JR
Br J Pharmacol; 1995 Jun; 115(3):401-8. PubMed ID: 7582449
[TBL] [Abstract][Full Text] [Related]
39. Enhancement of cytosolic calcium, prostacyclin and nitric oxide by bradykinin and the ACE inhibitor ramiprilat in porcine brain capillary endothelial cells.
Wiemer G; Popp R; Schölkens BA; Gögelein H
Brain Res; 1994 Feb; 638(1-2):261-6. PubMed ID: 7515323
[TBL] [Abstract][Full Text] [Related]
40. Differential sensitivities of the prostacyclin and nitric oxide biosynthetic pathways to cytosolic calcium in bovine aortic endothelial cells.
Parsaee H; McEwan JR; Joseph S; MacDermot J
Br J Pharmacol; 1992 Dec; 107(4):1013-9. PubMed ID: 1361398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]